Megakaryocyte lineage development is controlled by modulation of protein acetylation

Treatment with lysine deacetylase inhibitors (KDACi) for haematological malignancies, is accompanied by haematological side effects including thrombocytopenia, suggesting that modulation of protein acetylation affects normal myeloid development, and specifically megakaryocyte development. In the cur...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartels, Marije, Govers, Anita, Polak, Roel, Vervoort, Stephin, van Boxtel, Ruben, Pals, Cornelieke, Bierings, Marc, van Solinge, Wouter, Egberts, Toine, Nieuwenhuis, Edward, Mokry, Michal, Coffer, Paul James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919413/
https://www.ncbi.nlm.nih.gov/pubmed/29698469
http://dx.doi.org/10.1371/journal.pone.0196400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919413/
https://www.ncbi.nlm.nih.gov/pubmed/29698469
http://dx.doi.org/10.1371/journal.pone.0196400

Ejemplares similares